United States — Food and Drug Administration & Elanco

United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs related to Zoetis' Bedinvetmab, contributing to its weakening adoption.

Elanco: Elanco is a competitor to Zoetis, with its products Credelio Quattro and Ilunocitinib gaining market share from Zoetis' key companion animal products.

United States — Food and Drug Administration: The United States — Food and Drug Administration>>> granted emergency use authorization for several drugs to treat screwworm, aiding in the response to the outbreak.

Elanco: Elanco>>> shares rose as the company produces one of the animal treatments authorized for emergency use, suggesting potential benefits if the outbreak becomes more severe and increases demand for livestock drugs.